268 related articles for article (PubMed ID: 12835948)
1. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
2. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury.
Beschorner R; Nguyen TD; Gözalan F; Pedal I; Mattern R; Schluesener HJ; Meyermann R; Schwab JM
Acta Neuropathol; 2002 Jun; 103(6):541-9. PubMed ID: 12012085
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of CD68 and kallikrein 6 in human glioma.
Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
[TBL] [Abstract][Full Text] [Related]
4. The microglial/macrophagic response at the tumour-brain border of invasive meningiomas.
Grund S; Schittenhelm J; Roser F; Tatagiba M; Mawrin C; Kim YJ; Bornemann A
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):82-8. PubMed ID: 19187060
[TBL] [Abstract][Full Text] [Related]
5. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
6. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
9. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
12. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
[TBL] [Abstract][Full Text] [Related]
14. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
Lapointe M; Lanthier J; Moumdjian R; Régina A; Desrosiers RR
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):93-103. PubMed ID: 15857672
[TBL] [Abstract][Full Text] [Related]
15. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of frizzled 9 in astrocytomas.
Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas/APO-1 during the progression of astrocytomas.
Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H
Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627
[TBL] [Abstract][Full Text] [Related]
20. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]